MRK: Merck & Co., Inc. - Summary | Jitta

Merck & Co., Inc.

NYSE:MRK

Price
$92.08
Loss Chance
41.5%
7.32JITTA SCORE
113.36%Over Jitta Line
Jitta Ranking
46 / 1,195
771 / 5,119
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (71)
Recent Business Performance (84)
Financial Strength (69)
Return to Shareholders (91)
Competitive Advantage (78)
Jitta Signs
Revenue and EarningConsistent
Recent Business PerformanceEarning Growth Last Year
Operating MarginExpansion
Share RepurchaseEvery Year
Interest Coverage RatioVery Good
SG&A to SalesDecreasing Every Year
Key Stats
Jitta Score
Jitta Line
7.32
113.36%
1.94
91.44%
2.06
153.31%
Pharmaceuticals
6.66
21.76%
3.61
60.92%
6.49
64.71%
COMPANY DESCRIPTION
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.